全文获取类型
收费全文 | 7336篇 |
免费 | 793篇 |
国内免费 | 5篇 |
出版年
2022年 | 42篇 |
2021年 | 128篇 |
2020年 | 64篇 |
2019年 | 79篇 |
2018年 | 101篇 |
2017年 | 88篇 |
2016年 | 141篇 |
2015年 | 264篇 |
2014年 | 329篇 |
2013年 | 356篇 |
2012年 | 453篇 |
2011年 | 499篇 |
2010年 | 307篇 |
2009年 | 268篇 |
2008年 | 392篇 |
2007年 | 398篇 |
2006年 | 338篇 |
2005年 | 366篇 |
2004年 | 360篇 |
2003年 | 344篇 |
2002年 | 359篇 |
2001年 | 116篇 |
2000年 | 109篇 |
1999年 | 130篇 |
1998年 | 118篇 |
1997年 | 69篇 |
1996年 | 71篇 |
1995年 | 67篇 |
1994年 | 76篇 |
1993年 | 64篇 |
1992年 | 97篇 |
1991年 | 80篇 |
1990年 | 100篇 |
1989年 | 64篇 |
1988年 | 70篇 |
1987年 | 70篇 |
1986年 | 73篇 |
1985年 | 80篇 |
1984年 | 71篇 |
1983年 | 57篇 |
1982年 | 60篇 |
1981年 | 49篇 |
1980年 | 54篇 |
1979年 | 60篇 |
1978年 | 44篇 |
1977年 | 58篇 |
1976年 | 49篇 |
1975年 | 43篇 |
1974年 | 46篇 |
1973年 | 55篇 |
排序方式: 共有8134条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
F Stephen Perry 《BMJ (Clinical research ed.)》1998,317(7156):481
6.
7.
8.
Nataly Mancette Rijensky Netta R. Blondheim Shraga Eilon Barnea Nir Peled Eli Rosenbaum Aron Popovtzer Solomon M. Stemmer Alejandro Livoff Mark Shlapobersky Neta Moskovits Dafna Perry Eitan Rubin Itzhak Haviv Arie Admon 《Molecular & cellular proteomics : MCP》2020,19(8):1360-1374
Highlights
- •Sufficient tumor tissues are often unavailable large HLA peptidome discovery.
- •Using patient derived xenograft (PDX) tumors can overcome this limitation.
- •The large PDX HLA peptidomes expand significantly those of the original biopsies.
- •The HLA peptidomes of the PDX tumors included many tumor antigens.
9.
10.
Human Brain Microvascular Endothelial Cells Derived from the BC1 iPS Cell Line Exhibit a Blood-Brain Barrier Phenotype 总被引:1,自引:0,他引:1
The endothelial cells that form capillaries in the brain are highly specialized, with tight junctions that minimize paracellular transport and an array of broad-spectrum efflux pumps that make drug delivery to the brain extremely challenging. One of the major limitations in blood-brain barrier research and the development of drugs to treat central nervous system diseases is the lack of appropriate cell lines. Recent reports indicate that the derivation of human brain microvascular endothelial cells (hBMECs) from human induced pluripotent stem cells (iPSCs) may provide a solution to this problem. Here we demonstrate the derivation of hBMECs extended to two new human iPSC lines: BC1 and GFP-labeled BC1. These hBMECs highly express adherens and tight junction proteins VE-cadherin, ZO-1, occludin, and claudin-5. The addition of retinoic acid upregulates VE-cadherin expression, and results in a significant increase in transendothelial electrical resistance to physiological values. The permeabilities of tacrine, rhodamine 123, and Lucifer yellow are similar to values obtained for MDCK cells. The efflux ratio for rhodamine 123 across hBMECs is in the range 2–4 indicating polarization of efflux transporters. Using the rod assay to assess cell organization in small vessels and capillaries, we show that hBMECs resist elongation with decreasing diameter but show progressive axial alignment. The derivation of hBMECs with a blood-brain barrier phenotype from the BC1 cell line highlights that the protocol is robust. The expression of GFP in hBMECs derived from the BC1-GFP cell line provides an important new resource for BBB research. 相似文献